Literature DB >> 26315399

Cortical thickness predicts the first onset of major depression in adolescence.

Lara C Foland-Ross1, Matthew D Sacchet2, Gautam Prasad3, Brooke Gilbert4, Paul M Thompson3, Ian H Gotlib2.   

Abstract

Given the increasing prevalence of Major Depressive Disorder and recent advances in preventative treatments for this disorder, an important challenge in pediatric neuroimaging is the early identification of individuals at risk for depression. We examined whether machine learning can be used to predict the onset of depression at the individual level. Thirty-three never-disordered adolescents (10-15 years old) underwent structural MRI. Participants were followed for 5 years to monitor the emergence of clinically significant depressive symptoms. We used support vector machines (SVMs) to test whether baseline cortical thickness could reliably distinguish adolescents who develop depression from adolescents who remained free of any Axis I disorder. Accuracies from subsampled cross-validated classification were used to assess classifier performance. Baseline cortical thickness correctly predicted the future onset of depression with an overall accuracy of 70% (69% sensitivity, 70% specificity; p=0.021). Examination of SVM feature weights indicated that the right medial orbitofrontal, right precentral, left anterior cingulate, and bilateral insular cortex contributed most strongly to this classification. These findings indicate that cortical gray matter structure can predict the subsequent onset of depression. An important direction for future research is to elucidate mechanisms by which these anomalies in gray matter structure increase risk for developing this disorder.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cortical thickness; Depression; Emotion regulation; Machine learning

Mesh:

Year:  2015        PMID: 26315399      PMCID: PMC4604750          DOI: 10.1016/j.ijdevneu.2015.07.007

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  52 in total

Review 1.  The orbitofrontal cortex.

Authors:  E T Rolls
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1996-10-29       Impact factor: 6.237

2.  Treatment of adolescent depression: frequency of services and impact on functioning in young adulthood.

Authors:  P M Lewinsohn; P Rohde; J R Seeley
Journal:  Depress Anxiety       Date:  1998       Impact factor: 6.505

3.  Neural markers of familial risk for depression: An investigation of cortical thickness abnormalities in healthy adolescent daughters of mothers with recurrent depression.

Authors:  Lara C Foland-Ross; Brooke L Gilbert; Jutta Joormann; Ian H Gotlib
Journal:  J Abnorm Psychol       Date:  2015-08

4.  Gray matter volume and rapid decision-making in major depressive disorder.

Authors:  Masayuki Nakano; Koji Matsuo; Mami Nakashima; Toshio Matsubara; Kenichiro Harada; Kazuteru Egashira; Hiroaki Masaki; Kanji Takahashi; Yoshifumi Watanabe
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-09-25       Impact factor: 5.067

5.  Reduced volume of orbitofrontal cortex in major depression.

Authors:  J Douglas Bremner; Meena Vythilingam; Eric Vermetten; Ahsan Nazeer; Jahangir Adil; Sarfraz Khan; Lawrence H Staib; Dennis S Charney
Journal:  Biol Psychiatry       Date:  2002-02-15       Impact factor: 13.382

6.  Maternal history of reading difficulty is associated with reduced language-related gray matter in beginning readers.

Authors:  Jessica M Black; Hiroko Tanaka; Leanne Stanley; Masanori Nagamine; Nahal Zakerani; Alexandra Thurston; Shelli Kesler; Charles Hulme; Heikki Lyytinen; Gary H Glover; Christine Serrone; Mira M Raman; Allan L Reiss; Fumiko Hoeft
Journal:  Neuroimage       Date:  2011-10-17       Impact factor: 6.556

Review 7.  The prevention of adolescent depression.

Authors:  Tracy R G Gladstone; William R Beardslee; Erin E O'Connor
Journal:  Psychiatr Clin North Am       Date:  2011-03

8.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

Review 10.  Functional brain imaging studies of youth depression: a systematic review.

Authors:  Rebecca Kerestes; Christopher G Davey; Katerina Stephanou; Sarah Whittle; Ben J Harrison
Journal:  Neuroimage Clin       Date:  2013-12-11       Impact factor: 4.881

View more
  34 in total

1.  Brain areas associated with resilience to depression in high-risk young women.

Authors:  Birce Begum Burhanoglu; Gulsah Dinçer; Alpaslan Yilmaz; Ozgun Ozalay; Ozgul Uslu; Esmin Unaran; Omer Kitis; Ali Saffet Gonul
Journal:  Brain Struct Funct       Date:  2021-01-17       Impact factor: 3.270

2.  Increases in orbitofrontal cortex thickness following antidepressant treatment are associated with changes in resting state autonomic function in adolescents with major depression - Preliminary findings from a pilot study.

Authors:  Julian Koenig; Melinda Westlund Schreiner; Bonnie Klimes-Dougan; Benjamin Ubani; Bryon A Mueller; Kelvin O Lim; Michael Kaess; Kathryn R Cullen
Journal:  Psychiatry Res Neuroimaging       Date:  2018-08-24       Impact factor: 2.376

Review 3.  Machine learning studies on major brain diseases: 5-year trends of 2014-2018.

Authors:  Koji Sakai; Kei Yamada
Journal:  Jpn J Radiol       Date:  2018-11-29       Impact factor: 2.374

4.  Brain and behavioral correlates of insulin resistance in youth with depression and obesity.

Authors:  Manpreet K Singh; Sara M Leslie; Mary Melissa Packer; Yevgeniya V Zaiko; Owen R Phillips; Elizabeth F Weisman; Danielle M Wall; Booil Jo; Natalie Rasgon
Journal:  Horm Behav       Date:  2018-04-23       Impact factor: 3.587

Review 5.  Convergent neurobiological predictors of emergent psychopathology during adolescence.

Authors:  Scott A Jones; Angelica M Morales; Jessye B Lavine; Bonnie J Nagel
Journal:  Birth Defects Res       Date:  2017-12-01       Impact factor: 2.344

6.  Childhood abuse and reduced cortical thickness in brain regions involved in emotional processing.

Authors:  Andrea L Gold; Margaret A Sheridan; Matthew Peverill; Daniel S Busso; Hilary K Lambert; Sonia Alves; Daniel S Pine; Katie A McLaughlin
Journal:  J Child Psychol Psychiatry       Date:  2016-10       Impact factor: 8.982

7.  Cortical thickness is not associated with current depression in a clinical treatment study.

Authors:  Greg Perlman; Elizabeth Bartlett; Christine DeLorenzo; Myrna Weissman; Patrick McGrath; Todd Ogden; Tony Jin; Phillip Adams; Madhukar Trivedi; Benji Kurian; Maria Oquendo; Melvin McInnis; Sarah Weyandt; Maurizio Fava; Crystal Cooper; Ashley Malchow; Ramin Parsey
Journal:  Hum Brain Mapp       Date:  2017-06-08       Impact factor: 5.038

Review 8.  Translational application of neuroimaging in major depressive disorder: a review of psychoradiological studies.

Authors:  Ziqi Chen; Xiaoqi Huang; Qiyong Gong; Bharat B Biswal
Journal:  Front Med       Date:  2021-01-29       Impact factor: 4.592

Review 9.  Brain structure alterations in depression: Psychoradiological evidence.

Authors:  Fei-Fei Zhang; Wei Peng; John A Sweeney; Zhi-Yun Jia; Qi-Yong Gong
Journal:  CNS Neurosci Ther       Date:  2018-03-05       Impact factor: 5.243

10.  Pattern recognition of magnetic resonance imaging-based gray matter volume measurements classifies bipolar disorder and major depressive disorder.

Authors:  Harry Rubin-Falcone; Francesca Zanderigo; Binod Thapa-Chhetry; Martin Lan; Jeffrey M Miller; M Elizabeth Sublette; Maria A Oquendo; David J Hellerstein; Patrick J McGrath; Johnathan W Stewart; J John Mann
Journal:  J Affect Disord       Date:  2017-11-13       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.